Premium
EyePoint Inc (EYPT)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-25 | Mr. George O. ElstonExec. VP & CFO | 3,87k | 0,00 | Derivative Exercise and Retained Stock | - | 121,69k | 3,29% |
| 2026-05-25 | Mr. George O. ElstonExec. VP & CFO | -3,63k | 46,90k | Derivative Exercise and Sale | 12,93 | 121,69k | - |
| 2026-04-17 | Dr. Ramiro RibeiroChief Medical Officer | -2,44k | 16,43k | Derivative Exercise and Sale | 8,26 - 15,00 | 0,00 | - |
| 2026-03-23 | Dr. Jay S. DukerPresident, CEO & Director | -76,77k | 1,01M | Other Disposition | 13,11 | 178,42k | -30,08% |
| 2026-03-23 | Dr. Jay S. DukerPresident, CEO & Director | -150,00k | 0,00 | Other Derivative Disposition | 13,13 - 20,40 | 82,50k | -64,52% |
| 2026-03-16 | Dr. Jay S. DukerPresident, CEO & Director | 1,50k | 19,72k | Achat | 13,15 | 178,42k | 0,85% |
| 2026-03-02 | Mr. George O. ElstonExec. VP & CFO | -5,00k | 0,00 | Other Disposition | - | 117,82k | -4,07% |
| 2026-03-04 | Dr. Ramiro RibeiroChief Medical Officer | -2,44k | 23,43k | Derivative Exercise and Sale | 8,26 - 17,87 | 0,00 | - |
| 2026-02-17 | Dr. Ramiro RibeiroChief Medical Officer | -2,44k | 16,43k | Derivative Exercise and Sale | 8,26 - 15,00 | 0,00 | - |
| 2026-01-06 | Ms. Nancy S. LurkerVice Chair | 75,13k | 0,00 | Derivative Exercise and Retained Stock | - | 421,24k | 21,71% |
| 2026-01-06 | Dr. Jay S. DukerPresident, CEO & Director | 10,74k | 0,00 | Derivative Exercise and Retained Stock | - | 176,92k | 6,46% |
| 2026-01-06 | Dr. Jay S. DukerPresident, CEO & Director | -10,05k | 169,51k | Derivative Exercise and Sale | 16,86 | 176,92k | - |
| 2026-01-06 | Mr. George O. ElstonExec. VP & CFO | 10,80k | 0,00 | Derivative Exercise and Retained Stock | - | 116,85k | 10,18% |
| 2026-01-06 | Mr. George O. ElstonExec. VP & CFO | -4,49k | 75,65k | Derivative Exercise and Sale | 16,86 | 116,85k | - |
| 2026-01-05 | Dr. Ramiro RibeiroChief Medical Officer | -29,25k | 258,44k | Derivative Exercise and Sale | 8,26 - 17,10 | 0,00 | - |
| 2026-01-05 | Dr. Ramiro RibeiroChief Medical Officer | -13,29k | 227,27k | Vente | 17,10 | 0,00 | -100,00% |
| 2026-01-03 | Dr. Ramiro RibeiroChief Medical Officer | 13,29k | 0,00 | Derivative Exercise and Retained Stock | - | 13,29k | - |
| 2026-01-03 | Dr. Ramiro RibeiroChief Medical Officer | -6,37k | 111,40k | Derivative Exercise and Sale | 17,48 | 13,29k | - |
| 2026-01-03 | Mr. George O. ElstonExec. VP & CFO | 23,94k | 0,00 | Derivative Exercise and Retained Stock | - | 106,05k | 29,15% |
| 2026-01-03 | Mr. George O. ElstonExec. VP & CFO | -10,73k | 187,29k | Derivative Exercise and Sale | 17,43 - 17,48 | 106,05k | - |
| 2026-01-03 | Dr. Jay S. DukerPresident, CEO & Director | 57,05k | 0,00 | Derivative Exercise and Retained Stock | - | 166,18k | 52,28% |
| 2026-01-03 | Dr. Jay S. DukerPresident, CEO & Director | -37,95k | 662,68k | Derivative Exercise and Sale | 17,43 - 17,48 | 166,18k | - |
| 2026-01-05 | Ms. Nancy S. LurkerVice Chair | 12,67k | 0,00 | Derivative Exercise and Retained Stock | - | 346,10k | 3,80% |
| 2025-12-19 | Mr. George O. ElstonExec. VP & CFO | -5,00k | 0,00 | Other Disposition | - | 82,11k | -5,74% |
| 2025-12-04 | Cormorant Asset Management, LPSociété | -60,00k | 942,24k | Vente | 15,70 | 8,27M | -0,72% |
| 2025-12-04 | Ms. Nancy S. LurkerVice Chair | -9,30k | 140,48k | Vente | 15,11 | 333,44k | -2,71% |
| 2025-11-26 | Ms. Nancy S. LurkerVice Chair | -700,00 | 10,47k | Vente | 14,95 | 342,74k | -0,20% |
| 2025-11-11 | Dr. Ramiro RibeiroChief Medical Officer | -2,72k | 31,60k | Vente | 11,61 | 0,00 | -100,00% |
| 2025-09-19 | Mr. George O. ElstonExec. VP & CFO | -20,00k | 0,00 | Other Disposition | - | 82,11k | -19,59% |
| 2025-07-10 | Ms. Nancy S. LurkerVice Chair | 11,11k | 0,00 | Derivative Exercise and Retained Stock | - | 343,44k | 3,34% |
| 2025-07-10 | Dr. Jay S. DukerPresident, CEO & Director | 8,98k | 0,00 | Derivative Exercise and Retained Stock | - | 109,13k | 8,97% |
| 2025-07-10 | Dr. Jay S. DukerPresident, CEO & Director | -7,69k | 85,03k | Derivative Exercise and Sale | 11,06 | 109,13k | - |
| 2025-07-11 | Ms. Karen ZaderejIndependent Director | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 38,50k | 5,48% |
| 2025-07-02 | Ms. Nancy S. LurkerVice Chair | -232,02k | 0,00 | Other Derivative Disposition | 3,26 - 20,40 | 49,73k | -82,35% |
| 2025-06-23 | Dr. Jay S. DukerPresident, CEO & Director | -56,67k | 465,22k | Other Disposition | 8,21 | 100,15k | -36,13% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
